Trump Heading for Stay in Military Hospital for Covid Treatment, , on October 2, 2020 at 9:27 pm

Financial News
By
On October 2, 2020
In Financial News
Tags:

(Bloomberg) — President Donald Trump will be taken to Walter Reed National Military Medical Center on Friday to be treated for Covid-19, the White House said.“Out of an abundance of caution, and at the recommendation of his physician and medical experts, the president will be working from the presidential offices at Walter Reed for the next few days,” Press Secretary Kayleigh McEnany said in a statement.McEnany didn’t say what tests or treatments Trump would receive. She described his symptoms as “mild,” but the plan to send him to the hospital deepened questions about the severity of his illness just a month before the U.S. election.Trump is in “good spirits” after his Covid-19 diagnosis on Friday and has been treated with a Regeneron Pharmaceuticals Inc. “antibody cocktail,” the White House physician said.“Following PCR-confirmation of the president’s diagnosis, as a precautionary measure he received a single 8 gram dose of Regeneron’s” drug, the physician, Sean Conley, said in a statement released by McEnany.In addition to the antibodies, “the president has been taking zinc, vitamin D, famotidine, melatonin and a daily aspirin,” Conley said.Trump “remains fatigued but is in good spirits,” Conley said. First lady Melania Trump, who is also infected, “remains well with only a mild cough and headache,” he said.Regeneron shares spiked in late trading, rising more than 3% after the market closed in New York. The company’s experimental treatment for Covid-19 hasn’t been approved by the Food and Drug Administration, but Regeneron confirmed in a statement that it had provided a a single dose of the medicine for Trump’s use after receiving a “compassionate use” request from the president’s doctors.Trump and his wife have been in isolation at the White House since his diagnosis, which he announced after Bloomberg News reported that one of his closest aides, Hope Hicks, had tested positive for coronavirus infection.Conley’s statement was the first update from Trump’s doctor since early Friday morning. The president has not tweeted or made any public statement since announcing his infection at 12:54 a.m. in Washington.Trump learned of Hicks’s positive test Thursday morning but continued with his planned schedule for the day, including a fundraiser at his Bedminster, New Jersey golf resort that raised $5 million for his campaign, according to people familiar with the matter.Trump and Hicks had been in close contact in the days before her diagnosis. She traveled with him to the presidential debate in Cleveland on Tuesday and to campaign events in Minnesota on Wednesday.Hicks tested negative for infection Wednesday morning, then fell ill in Minnesota and was isolated on the flight back to Washington aboard Air Force One, according to people familiar with the matter.(Updates with Regeneron statement in fifth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.,

Trump Heading for Stay in Military Hospital for Covid Treatment(Bloomberg) — President Donald Trump will be taken to Walter Reed National Military Medical Center on Friday to be treated for Covid-19, the White House said.“Out of an abundance of caution, and at the recommendation of his physician and medical experts, the president will be working from the presidential offices at Walter Reed for the next few days,” Press Secretary Kayleigh McEnany said in a statement.McEnany didn’t say what tests or treatments Trump would receive. She described his symptoms as “mild,” but the plan to send him to the hospital deepened questions about the severity of his illness just a month before the U.S. election.Trump is in “good spirits” after his Covid-19 diagnosis on Friday and has been treated with a Regeneron Pharmaceuticals Inc. “antibody cocktail,” the White House physician said.“Following PCR-confirmation of the president’s diagnosis, as a precautionary measure he received a single 8 gram dose of Regeneron’s” drug, the physician, Sean Conley, said in a statement released by McEnany.In addition to the antibodies, “the president has been taking zinc, vitamin D, famotidine, melatonin and a daily aspirin,” Conley said.Trump “remains fatigued but is in good spirits,” Conley said. First lady Melania Trump, who is also infected, “remains well with only a mild cough and headache,” he said.Regeneron shares spiked in late trading, rising more than 3% after the market closed in New York. The company’s experimental treatment for Covid-19 hasn’t been approved by the Food and Drug Administration, but Regeneron confirmed in a statement that it had provided a a single dose of the medicine for Trump’s use after receiving a “compassionate use” request from the president’s doctors.Trump and his wife have been in isolation at the White House since his diagnosis, which he announced after Bloomberg News reported that one of his closest aides, Hope Hicks, had tested positive for coronavirus infection.Conley’s statement was the first update from Trump’s doctor since early Friday morning. The president has not tweeted or made any public statement since announcing his infection at 12:54 a.m. in Washington.Trump learned of Hicks’s positive test Thursday morning but continued with his planned schedule for the day, including a fundraiser at his Bedminster, New Jersey golf resort that raised $5 million for his campaign, according to people familiar with the matter.Trump and Hicks had been in close contact in the days before her diagnosis. She traveled with him to the presidential debate in Cleveland on Tuesday and to campaign events in Minnesota on Wednesday.Hicks tested negative for infection Wednesday morning, then fell ill in Minnesota and was isolated on the flight back to Washington aboard Air Force One, according to people familiar with the matter.(Updates with Regeneron statement in fifth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

168 Robinson Road,
Capital Tower, Singapore 068912
+65 3105 1295

Taiwan

5th Floor, No. 1-8, Section 5, Zhongxiao East Road, Taipei

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Australia

44 Martin Place, Sydney 2000 Australia
+02 8319 3232

Indonesia

Millennium Centennial Center, 38th Floor, Jl. Jend. Sudirman Kav. 25
Jakarta 12920, Indonesia

Market Coverage